Alpha 1 Antitrypsin Deficiency & COPD
Alpha-1 antitrypsin deficiency is a genetic disorder that is passed on in families and affects the lungs, liver and skin. When this condition affects the lungs, it causes COPD. There is no cure, but treatment can help people with Alpha-1 antitrypsin deficiency manage their symptoms and live a better life. The preliminary symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing. Other signs and symptoms include unintentional weight loss, recurring respiratory infections, fatigue, and rapid heartbeat upon standing. Affected individuals often develop emphysema, which is a lung disease caused by damage to the small air sacs in the lungs. Alpha-1 antitrypsin deficiency accounts for 1 to 2% of all cases of chronic obstructive pulmonary disease.
Related Conference of Alpha 1 Antitrypsin Deficiency & COPD
17th International Conference on Chronic Obstructive Pulmonary Disease
14th International Conference on COPD Clinical Trials & Lung Care Advances
16th International Conference on Pulmonary & Respiratory Medicine
Alpha 1 Antitrypsin Deficiency & COPD Conference Speakers
Recommended Sessions
- Asthma
- Chronic Obstructive Pulmonary Disease
- Alpha 1 Antitrypsin Deficiency & COPD
- Cardiopulmonary Disorders
- Clinical management of severe acute respiratory infection
- COVID-19 Treatment and Recovery
- Covid19 Vaccine and Lung Immunopathology
- Cystic Fibrosis
- Depression and anxiety in COPD
- Diagnosis and Treatment of COPD
- Digital Health in Respiratory Care
- Effect of COVID-19 on Lungs
- Genetic risk factor of COPD
- Idiopathic Pulmonary Fibrosis
- Innate Immunity and Lung Fibrosis
- Investigational Drugs and Other Therapies in the treatment of Respiratory Disease
- Lung cancer
- Lung Cancer Diagnosis & Treatment
- Pathology and Clinical Management of COPD
- Pneumonia
- Pulmonary Rehabilitation
- Respiratory Diseases
- Severe Acute Respiratory Syndrome (SARS)
- Sleep apnea
- Tuberculosis
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Epidemiology of COPD - COPD_2025 (Spain)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Types of COPD - COPD_2025 (Spain)

